NMDP/Be The Match® PTCy Research Levels the Field between Matched and Mismatched Hematopoietic Cell Transplantation
Research shows no discernable differences in graft versus host disease, relapse free survival or overall survival for patients who had a Hematopoietic Cell Transplant (HCT) with an 8/8 or 7/8 Unrelated Donor (URD) for adult patients with malignancies.